keyword
MENU ▼
Read by QxMD icon Read
search

rhinoconjunctivitys in pediatrics

keyword
https://www.readbyqxmd.com/read/29018501/quality-of-life-in-pediatric-patients-with-allergic-rhinitis-treated-at-the-medical-clinic-of-integrated-education-unisul
#1
Mariana Dziekanski, Taíse de Freitas Marcelino
Introduction  Allergic rhinitis is a common disease among children and adolescents, reaching up to 40% of the population. During childhood, it is usually underdiagnosed because it has nonspecific symptoms. It has a negative impact on quality of life and may predispose to comorbidities. The diagnosis is clinical and treatment aims prevention. Objective  The objective of this study is to evaluate the quality of life in pediatric patients with allergic rhinitis. Methods This is an observational study with cross-sectional design...
October 2017: International Archives of Otorhinolaryngology
https://www.readbyqxmd.com/read/28734858/safety-review-of-5-grass-pollen-tablet-from-pooled-data-of-clinical-trials
#2
Thomas B Casale, Linda S Cox, Ulrich Wahn, David B K Golden, Brigitte Bons, Alain Didier
BACKGROUND: The 5-grass pollen sublingual tablet has been approved for the treatment of grass pollen-induced allergic rhinoconjunctivitis in subjects with or without intermittent asthma. OBJECTIVE: To provide a comprehensive analysis of the safety profile of the 5-grass tablet on the basis of pooled data from 8 clinical trials. METHODS: Subjects (5-65 years old) with medically confirmed grass pollen-induced allergic rhinoconjunctivitis were included in the double-blind studies...
July 19, 2017: Journal of Allergy and Clinical Immunology in Practice
https://www.readbyqxmd.com/read/28490400/association-of-pediatric-allergic-rhinitis-with-the-ratings-of-attention-deficit-hyperactivity-disorder
#3
Bohai Feng, Haiyong Jin, Haijie Xiang, Bangliang Li, Xiuxiu Zheng, Ruru Chen, Yunbin Shi, Si Chen, Bobei Chen
BACKGROUND: Allergic rhinitis (AR) is currently the most prevalent allergic disease in children and adolescents. OBJECTIVE: Surveys conducted by population-based studies of East Asia revealed an increased prevalence of behavioral disorders in patients with AR. Thus, in this study, we explored the prevalence of attention-deficit/hyperactivity disorder (ADHD) in pediatric patients with AR. METHODS: A total of 333 children (6-12 years of age) with AR and a total of 322 age-matched controls were included in this study...
May 1, 2017: American Journal of Rhinology & Allergy
https://www.readbyqxmd.com/read/28294586/pediatric-eosinophilic-esophagitis-in-portugal
#4
J L Alves Marcelino, R Cardoso de Aguiar, F Cabral Duarte, A Célia Costa, M A Pereira-Barbosa
Eosinophilic esophagitis (EoE) is an increasingly frequent diagnosis in our clinical practice, mainly in pediatric age. Allergic responses to food and aeroallergens have been increasingly implicated in the etiology of this disease. We describe a retrospective data analysis of pediatric EoE patients followed in our Immunoallergology Department. Of the 25 children (22 male, average 10.8 years), 88% had prior history of rhinoconjunctivitis, 76% asthma, 48% eczema and 36% food allergy. After evaluation, we identified in 76% and 92% of patients food and aeroallergen sensitization, respectively; 68% had simultaneously food and inhalant sensitization and 96% had at least one positive test to aeroallergens or food allergens...
March 2017: European Annals of Allergy and Clinical Immunology
https://www.readbyqxmd.com/read/28293909/allergen-immunotherapy-clinical-trial-outcomes-and-design-working-toward-harmonization-of-methods-and-principles
#5
REVIEW
Harold S Nelson, Moises A Calderon, David I Bernstein, Thomas B Casale, Stephen R Durham, Jens S Andersen, Robert Esch, Linda S Cox, Hendrik Nolte
Progress has been made in the harmonization of efficacy and safety outcome measures for allergen immunotherapy (AIT) trials, but unresolved issues still remain. Furthermore, there are discrepancies in recommendations from professional medical societies and regulatory agencies regarding requirements for AIT trials. In this article, we reviewed published recommendations and current data from recent clinical trials, as well as the criteria applied by regulatory authorities for approval of AIT products, to provide updated considerations for conducting phase 3 AIT trials...
March 2017: Current Allergy and Asthma Reports
https://www.readbyqxmd.com/read/26999633/endotypes-of-pollen-food-syndrome-in-children-with-seasonal-allergic-rhinoconjunctivitis-a-molecular-classification
#6
C Mastrorilli, S Tripodi, C Caffarelli, S Perna, A Di Rienzo-Businco, I Sfika, R Asero, A Dondi, A Bianchi, C Povesi Dascola, G Ricci, F Cipriani, N Maiello, M Miraglia Del Giudice, T Frediani, S Frediani, F Macrì, C Pistoletti, I Dello Iacono, M F Patria, E Varin, D Peroni, P Comberiati, L Chini, V Moschese, S Lucarelli, R Bernardini, G Pingitore, U Pelosi, R Olcese, M Moretti, A Cirisano, D Faggian, A Travaglini, M Plebani, M C Verga, M Calvani, P Giordani, P M Matricardi
BACKGROUND: Pollen-food syndrome (PFS) is heterogeneous with regard to triggers, severity, natural history, comorbidities, and response to treatment. Our study aimed to classify different endotypes of PFS based on IgE sensitization to panallergens. METHODS: We examined 1271 Italian children (age 4-18 years) with seasonal allergic rhinoconjunctivitis (SAR). Foods triggering PFS were acquired by questionnaire. Skin prick tests were performed with commercial pollen extracts...
August 2016: Allergy
https://www.readbyqxmd.com/read/26514931/nasal-saline-irrigation-with-or-without-systemic-antibiotics-in-treatment-of-children-with-acute-rhinosinusitis
#7
RANDOMIZED CONTROLLED TRIAL
Ahmed Ragab, Taghreed Farahat, Ghada Al-Hendawy, Rehab Samaka, Seham Ragab, Amira El-Ghobashy
OBJECTIVES: Acute rhinosinusitis (ARS) is a common pediatric problem. Our aim was to determine the efficacy of normal nasal saline irrigation (NSI) with or without amoxicillin in treatment of acute rhinosinusitis (ARS) in children. METHODS: It is a prospective randomized, blind placebo-controlled trial. Children with uncomplicated ARS were recruited. One group received (amoxacillin 100mg/kg/day) and 0.9% NSI. The second group received placebo and 0.9% NSI. The primary outcome was the effect of treatment on clinical response...
December 2015: International Journal of Pediatric Otorhinolaryngology
https://www.readbyqxmd.com/read/26495999/pediatric-investigation-plans-for-specific-immunotherapy-questionable-contributions-to-childhood-health
#8
Klaus Rose, Matthias Volkmar Kopp
Allergen-specific immunotherapy (SIT) is the only disease-modifying treatment for children, adolescents, and adults with allergic diseases. The EU has a combined system of national and EU-wide marketing authorization for all medicines. Germany introduced a new therapy allergen ordinance in 2008. Allergen products manufacturers had to apply for marketing authorization application for the major allergen groups (grass group, birch group, mites group, bee/wasp venom). Due to the EU pediatric regulation, in force since 2007, manufacturers had also to submit a pediatric investigation plan (PIP) for each allergen product...
December 2015: Pediatric Allergy and Immunology
https://www.readbyqxmd.com/read/26120539/guideline-on-allergen-specific-immunotherapy-in-ige-mediated-allergic-diseases-s2k-guideline-of-the-german-society-for-allergology-and-clinical-immunology-dgaki-the-society-for-pediatric-allergy-and-environmental-medicine-gpa-the-medical-association-of-german
#9
Oliver Pfaar, Claus Bachert, Albrecht Bufe, Roland Buhl, Christof Ebner, Peter Eng, Frank Friedrichs, Thomas Fuchs, Eckard Hamelmann, Doris Hartwig-Bade, Thomas Hering, Isidor Huttegger, Kirsten Jung, Ludger Klimek, Matthias Volkmar Kopp, Hans Merk, Uta Rabe, Joachim Saloga, Peter Schmid-Grendelmeier, Antje Schuster, Nicolaus Schwerk, Helmut Sitter, Ulrich Umpfenbach, Bettina Wedi, Stefan Wöhrl, Margitta Worm, Jörg Kleine-Tebbe, Susanne Kaul, Anja Schwalfenberg
The present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by the German, Austrian and Swiss professional associations for allergy in consensus with the scientific specialist societies and professional associations in the fields of otolaryngology, dermatology and venereology, pediatric and adolescent medicine, pneumology as well as a German patient organization (German Allergy and Asthma Association; Deutscher Allergie- und Asthmabund, DAAB) according to the criteria of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF)...
2014: Allergo Journal International
https://www.readbyqxmd.com/read/25985708/the-effect-of-exercise-on-exhaled-nitric-oxide-depends-on-allergic-rhinoconjunctivitis-in-children
#10
Bjørg Evjenth, Tonje E Hansen, Jan Holt
OBJECTIVE: Fractional exhaled nitric oxide (FENO) and exercise testing are widely used for the evaluation of pediatric asthma. The evidence relating to the effects of strenuous exercise on FENO in children is conflicting. Little information is available on the association between exercise and FENO in relation to allergic rhinoconjunctivitis (AR). We aimed to investigate the effects of AR on children's FENO in response to a standardized treadmill exercise test. METHODS: A total of 124 children with current asthma and 124 non-asthmatic children aged 8-16 years were studied...
October 2015: Journal of Asthma: Official Journal of the Association for the Care of Asthma
https://www.readbyqxmd.com/read/25335122/300ir-5-grass-pollen-sublingual-tablet-offers-relief-from-nasal-symptoms-in-patients-with-allergic-rhinitis
#11
REVIEW
Elie Serrano, Hans Ulrich Wahn, Alain Didier, Claus Bachert
BACKGROUND: 300IR 5-grass pollen sublingual immunotherapy tablets have been approved for the treatment of allergic rhinitis (AR) with or without conjunctivitis in adults and children >5 years with grass pollen allergy. This study was designed to review data on nasal symptoms with 300IR 5-grass pollen sublingual tablets in adults and children. METHODS: We reviewed data from four double-blind, placebo-controlled, randomized clinical trials. Two groups of patients who received a daily dose of either placebo or 300IR 5-grass pollen sublingual tablets starting 4 months before the expected start of the pollen season and continuing through the season were compared (analysis of covariance) for scores of sneezing, rhinorrhea, nasal pruritus, nasal congestion, total nasal symptom score (TNSS), and adult Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) scores...
November 2014: American Journal of Rhinology & Allergy
https://www.readbyqxmd.com/read/25188717/sublingual-immunotherapy-in-children-the-recent-experiences
#12
REVIEW
Nicole Pleskovic, Ashton Bartholow, David P Skoner
PURPOSE OF REVIEW: Sublingual immunotherapy (SLIT) is indicated for the use in pediatric patients suffering from allergic rhinitis or allergic rhinoconjunctivitis caused by environmental allergens, such as ragweed pollen, grass pollen, and dust mite. This review focuses on recent and relevant studies associated with the use of SLIT for these allergens in children by examining efficacy, safety, and immunological data in comparison to subcutaneous immunotherapy, therapeutic treatments, and placebo...
December 2014: Current Opinion in Allergy and Clinical Immunology
https://www.readbyqxmd.com/read/24988740/-the-prevalence-of-symptoms-of-allergic-diseases-among-younger-school-children-in-medimurje-county-isaac-phase-i
#13
Helena Munivrana Skvorc, Davor Plavec, Stefanija Munivrana, Marko Skvorc, Boro Nogalo, Mirjana Turkalj
OBJECTIVE: To estimate the prevalence of symptoms of asthma, allergic rhinitis/rhinoconjuctivitis and atopic eczema symptoms in the Medimurje County in Northwest Croatia. SUBJECTS AND METHODS: The study was undertaken between January and April 2005 among school children in 27 randomly selected elementary schools. Data were collected using standardized ISAAC written questionnaire Phase I. RESULTS: A total of 3106 children participated in the study (7-9 yrs) with response rate 96...
March 2014: Lijec̆nic̆ki Vjesnik
https://www.readbyqxmd.com/read/24812522/economic-evaluation-of-sq-standardized-grass-allergy-immunotherapy-tablet-grazax-%C3%A2-in-children
#14
Sarah Ronaldson, Matthew Taylor, Peter G Bech, Ruth Shenton, Albrecht Bufe
BACKGROUND: Grass pollen-induced rhinoconjunctivitis is a common allergic respiratory disorder affecting over 20% of the UK population in terms of quality of life and sleep, work, and school patterns. The SQ-standardized grass allergy immunotherapy tablet (AIT) has been demonstrated as a disease-modifying treatment which gives a sustained effect even after completion of a treatment course. The objective of this study was to provide an economic assessment of whether treatment with the SQ-standardized grass AIT, Grazax(®) (Phleum pratense) in combination with symptomatic medications is preferable to the standard of care using symptomatic medications only...
2014: ClinicoEconomics and Outcomes Research: CEOR
https://www.readbyqxmd.com/read/24781917/patient-reported-outcomes-and-quality-of-life-questionnaires-in-the-assessment-of-rhinoconjunctivitis-in-childhood
#15
Désirée Larenas-Linnemann, Oliver Pfaar
PURPOSE OF REVIEW: Rhinoconjunctivitis, and especially allergic rhinoconjunctivitis (ARC) are increasing in prevalence, progressively affecting the well being of more and more adults and children. Clinical trials using allergen immunotherapy (AIT), the sole causal treatment of allergies, are being conducted, but discussions on optimal patient-related outcomes (PROs) are still ongoing. RECENT FINDINGS: Almost all publications discussing PROs relate to adults. The authors comment on the importance of broader PROs when assessing the results of AIT trials, as focusing on only nasal symptom improvement and medication reduction does not capture the full benefit of AIT...
June 2014: Current Opinion in Allergy and Clinical Immunology
https://www.readbyqxmd.com/read/24468255/efficacy-and-safety-of-grass-sublingual-immunotherapy-tablet-mk-7243-a-large-randomized-controlled-trial
#16
RANDOMIZED CONTROLLED TRIAL
Jennifer Maloney, David I Bernstein, Harold Nelson, Peter Creticos, Jacques Hébert, Michael Noonan, David Skoner, Yijie Zhou, Amarjot Kaur, Hendrik Nolte
BACKGROUND: In North America, few studies have evaluated sublingual immunotherapy for allergic rhinitis with or without conjunctivitis (AR/C); pediatric data are sparse. The authors report findings from the largest published immunotherapy trial yet conducted in adults and children. OBJECTIVE: To evaluate grass sublingual immunotherapy tablet (MK-7243) treatment in subjects with AR/C. METHODS: North American subjects (5-65 years old) with grass allergy were randomized 1:1 to once-daily MK-7243 (2,800 BAU Phleum pratense) or placebo...
February 2014: Annals of Allergy, Asthma & Immunology
https://www.readbyqxmd.com/read/24269033/evaluation-of-the-effect-of-lactobacillus-paracasei-hf-a00232-in-children-6-13-years-old-with-perennial-allergic-rhinitis-a-12-week-double-blind-randomized-placebo-controlled-study
#17
RANDOMIZED CONTROLLED TRIAL
Wen-Ya Lin, Lin-Shien Fu, Heng-Kuei Lin, Chian-Yin Shen, Yee-Jun Chen
INTRODUCTION: Dietary supplementation with probiotics alters intestinal microflora of children and may have immunomodulatory effects in prevention of allergic diseases. The aim of this study was to evaluate the effects of Lactobacillus paracasei (LP), strain HF.A00232, as a supplementary agent to levocetirizine in treating children with perennial allergic rhinitis (AR). METHODS: This study was a 12-week, double-blind, randomized, placebo-controlled trial. Sixty children with AR aged 6-13 years with nasal total symptoms score (NTSS) ≥5 who fulfilled the inclusion criteria were enrolled...
June 2014: Pediatrics and Neonatology
https://www.readbyqxmd.com/read/24260979/a-multicenter-study-of-sensitization-profiles-in-an-allergic-pediatric-population-in-an-area-with-high-allergen-exposure
#18
A Feliu, D González-de-Olano, E González, B Rodriguez, J Ruiz-Hornillos, L Jimeno, F de la Torre
BACKGROUND AND OBJECTIVE: In areas with a high number of allergens and high allergen concentrations, it is essential to identify the main causes of allergy, especially in pediatric patients. This study was conducted in allergic patients aged 14 or less to identify sensitization profiles during an initial phase, and to then evaluate changes in these profiles after 3 years of follow-up. This article describes the first phase of our investigation. METHODS: A total of 187 patients aged between 2 and 14 years were included by 5 allergy units; all the children had symptoms suggestive of allergic disease (rhinoconjunctivitis andlor asthma)...
2013: Journal of Investigational Allergology & Clinical Immunology
https://www.readbyqxmd.com/read/24236692/pollen-induced-allergic-rhinitis-in-1360-italian-children-comorbidities-and-determinants-of-severity
#19
Arianna Dondi, Salvatore Tripodi, Valentina Panetta, Riccardo Asero, Andrea Di Rienzo Businco, Annamaria Bianchi, Antonio Carlucci, Giampaolo Ricci, Federica Bellini, Nunzia Maiello, Michele Miraglia del Giudice, Tullio Frediani, Simona Sodano, Iride Dello Iacono, Francesco Macrì, Valerio Massaccesi, Carlo Caffarelli, Laura Rinaldi, Maria Francesca Patria, Elena Varin, Diego Peroni, Iolanda Chinellato, Loredana Chini, Viviana Moschese, Sandra Lucarelli, Roberto Bernardini, Giuseppe Pingitore, Umberto Pelosi, Mariangela Tosca, Francesco Paravati, Stefania La Grutta, Paolo Meglio, Mauro Calvani, Mario Plebani, Paolo Maria Matricardi
BACKGROUND: Pollen-induced allergic rhinoconjunctivitis (AR) is highly prevalent and rapidly evolving during childhood. General practitioners may not be fully aware of the nature and severity of symptoms experienced by patients and might underestimate the prevalence of moderate or severe disease. Thus, the relevance of early diagnosis and intervention may be overlooked. OBJECTIVES: To investigate the severity of pollen-induced AR and its determinants in Italian children referred to allergy specialists and who had never received specific immunotherapy (SIT)...
December 2013: Pediatric Allergy and Immunology
https://www.readbyqxmd.com/read/23703065/component-resolved-diagnosis-in-pediatric-allergic-rhinoconjunctivitis-and-asthma
#20
REVIEW
Giovanni Melioli, Giovanni Passalacqua, Giorgio Walter Canonica, Carlos E Baena-Cagnani, Paolo Matricardi
PURPOSE OF REVIEW: The aim of this review is to update readers on the growing impact of a molecular approach (CRD) to the diagnosis and treatment of children with respiratory allergies RECENT FINDINGS: A large panel of highly purified natural or recombinant species-specific and cross-reacting allergenic molecules is now available for clinical purposes. Species-specific molecules allow identifying specific sensitization toward a given allergenic source. Cross-reacting molecules allow interpreting polysensitization patterns that cannot be detailed using routine skin prick tests or specific IgE tests based on allergenic extracts...
August 2013: Current Opinion in Allergy and Clinical Immunology
keyword
keyword
102239
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"